Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07186543 · ClinicalTrials.gov registry record · NA

Co-Designing a Virtual Reality Intervention to Enhance Skill Development

A NA study of Suicide, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT07186543: Recruiting NA study of Suicide, sponsored by University of North Carolina, Chapel Hill.

NCT07186543 is a NA study of Suicide that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 26 participants, below the 6,990-participant average among 92 other Suicide trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07186543, a NA study of Suicide, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

This study is refining and pilot testing a novel Virtual Reality (VR) supplement for inpatient treatment: the Practice Experiences for School Reintegration (PrESR) program. The PrESR provides immersive school and social experiences for inpatient adolescents (with suicidal-related admissions) to practice skills in real-world settings with the guidance of a trained clinician within the confines of a hospital. The initial intervention was based on feedback from adolescent hospitalized for suicide-related crises, and school and hospital professionals, but did not provide tailored experiences to address the individual needs of ethnic-racial, gender, and sexual minoritized adolescents. Therefore, the VR environment of PrESR was adapted based on input from adolescents with previous suicide-related crises identifying as ethnic, racial, sex, or gender minoritized. This pilot randomized controlled trial (RCT) aims to explore the feasibility, acceptability, and facilitators/barriers to implementation of the adapted version of PrESR for improving outcomes in hospitalized adolescents. This study is not powered to test hypotheses; however, in addition to assessing feasibility, acceptability, and barriers/facilitators, this pilot trial will assess candidate intermediary and outcome measures.

Primary Outcome

Recruitment rate determined based on the proportion of adolescents providing assent and parents or legal guardians providing permission relative to the number of parents or legal guardians approached.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy (CBT) Worksheets
  • BEHAVIORAL Practice Experiences for School Reintegration (PrESR)

Study Locations (1)

North Carolina

  • UNC Adolescent Psychiatry Inpatient Unit - Chapel Hill

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2025-10-13
Est. Completion 2026-10-30
Phase NA

What NCT07186543 shows while recruiting

NCT07186543 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 6,990-participant average among 92 other Suicide trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) Worksheets is the first listed.

NCT07186543 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07186543 about?

NCT07186543 is a clinical study titled "Co-Designing a Virtual Reality Intervention to Enhance Skill Development". This study is refining and pilot testing a novel Virtual Reality (VR) supplement for inpatient treatment: the Practice Experiences for School Reintegration (PrESR) program. The PrESR provides immersive school and social experiences for inpatient adolescents (with suicidal-related admissions) to prac...

What is the current status of trial NCT07186543?

This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2025-10-13. Estimated completion is 2026-10-30.

What conditions does trial NCT07186543 study?

This clinical trial studies the following conditions: Suicide.

What interventions are being tested in trial NCT07186543?

The interventions under investigation include: Cognitive Behavioral Therapy (CBT) Worksheets (BEHAVIORAL), Practice Experiences for School Reintegration (PrESR) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07186543?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07186543 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07186543's enrollment target sits among peer trials

26 83rd of 92 higher than 9 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07186543, the US trial registry maintained by the National Library of Medicine. NCT07186543 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.